151 related articles for article (PubMed ID: 16429314)
1. Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
Knudsen A; Monstad SE; Dørum A; Lønning PE; Salvesen HB; Drivsholm L; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2006 Oct; 55(10):1280-4. PubMed ID: 16429314
[TBL] [Abstract][Full Text] [Related]
2. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
[TBL] [Abstract][Full Text] [Related]
3. CRMP5 antibodies in patients with small-cell lung cancer or thymoma.
Monstad SE; Drivsholm L; Skeie GO; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2008 Feb; 57(2):227-32. PubMed ID: 17657489
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
Stich O; Rasiah C; Rauer S
Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
[TBL] [Abstract][Full Text] [Related]
5. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
6. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma.
Saiz A; Dalmau J; Butler MH; Chen Q; Delattre JY; De Camilli P; Graus F
J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):214-7. PubMed ID: 10071102
[TBL] [Abstract][Full Text] [Related]
7. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
9. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
10. Avidity of onconeural antibodies is of clinical relevance.
Totland C; Ying M; Haugen M; Mazengia K; Storstein A; Aarseth J; Martinez A; Vedeler C
Cancer Immunol Immunother; 2013 Aug; 62(8):1393-6. PubMed ID: 23733227
[TBL] [Abstract][Full Text] [Related]
11. Onconeural antibodies in sera from patients with various types of tumours.
Monstad SE; Knudsen A; Salvesen HB; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2009 Nov; 58(11):1795-800. PubMed ID: 19294382
[TBL] [Abstract][Full Text] [Related]
12. Ondine's curse in anti-Ri antibody associated paraneoplastic brainstem syndrome.
Kim KJ; Yun JY; Lee JY; Kim YE; Jeon BS
Sleep Med; 2013 Apr; 14(4):382. PubMed ID: 23232043
[No Abstract] [Full Text] [Related]
13. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.
Drlicek M; Bianchi G; Bogliun G; Casati B; Grisold W; Kolig C; Liszka-Setinek U; Marzorati L; Wondrusch E; Cavaletti G
J Neurol; 1997 Feb; 244(2):85-9. PubMed ID: 9120501
[TBL] [Abstract][Full Text] [Related]
14. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
15. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
16. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
17. Antineuronal antibodies in small cell lung carcinoma--a significance for paraneoplastic syndromes?
Grisold W; Drlicek M; Popp W; Jellinger K
Acta Neuropathol; 1987; 75(2):199-202. PubMed ID: 2829498
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmoplegia associated with the anti-Ri antibody.
Ohmer R; Golnik KC; Richards AI; Kosmorsky GS
J Neuroophthalmol; 1999 Dec; 19(4):246-8. PubMed ID: 10608678
[TBL] [Abstract][Full Text] [Related]
20. Onconeural antibodies: improved detection and clinical correlations.
Storstein A; Monstad SE; Haugen M; Mazengia K; Veltman D; Lohndal E; Aarseth J; Vedeler C
J Neuroimmunol; 2011 Mar; 232(1-2):166-70. PubMed ID: 21093932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
